Rhian M Touyz, PhD | VEGF signaling, anti-cancer drugs and hypertension

February 12, 2016 by School of Medicine Webmaster

Date: Friday March 18, 2016
Time: 12:00 PM until AM
Location: Battle Building, Quayle Learning Center

VEGF Signaling, Anti-Cancer Drugs and Hypertension

Photo of Rhian M Touyz

Professor Rhian M Touyz MBBCh, PhD, FRCP, FRSE

British Heart Foundation Chair of Cardiovascular Medicine
Director – Institute of Cardiovascular & Medical Sciences
BHF Glasgow Cardiovascular Research Centre


  • Cardiovascular effects of modern anti-cancer agents.
  • VEGF inhibitors (VEGFI) and the relationship to hypertension.
  • VEGF and tyrosine kinase signaling and vascular function
  • Potential molecular and vascular mechanisms underlying VEGFI-induced hypertension

*lunch available at 11:30 – please RSVP: Wendy Cline – cline@virginia.edu*

Contact cline@virginia.edu for more information